Close Menu

software developers

The Wellcome Trust has granted the University of Dundee five more years of support to help bioinformaticians develop a web-compatible JavaScript version of the software.

Startup healthcare analytics company Progknowse will work with hospitals and sequencing labs to build a clinical and genomic dataset.

Tabula Rasa Healthcare will deliver pharmacogenomics test results from CQuentia's lab, while CQuentia will supply analytics and biometric wearables.

Michigan-based Advaita Bioinformatics wants to be a one-stop shop for proteomics, transcriptomics, and variant analysis, as well as internet omics search.

The California-based health system is expanding its partnership with clinical decision support vendor CancerIQ to integrate risk assessment into the Cerner EHR workflow.

The company formerly known as TransMed Systems looks to bring "clarity and transparency" to the emerging field of precision oncology and in patient-trial matching.

With $50 million from Japanese firm NEC, biomedical software startup BostonGene seeks to assess patients' "immune fitness" in the quest for better therapies.

Following an April hackathon and work from Melbourne Genomics and Fred Hutch, the Broad is about to release a long-awaited AWS version of its Cromwell workflow engine.

Vendors look to augment, not replace, genetic counselors with consumer-friendly technology, including AI-driven online chats and decision support systems.

Japanese software giant NEC invests in AI-centric software company BostonGene to advance immuno-oncology and other targeted cancer treatments.

Pages

The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.

In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.

MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.

In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.